FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and constitutes a method for synthesis of D-psicose comprising: a stage of placing a composition containing a D-psicose borate complex in a chromatographic system containing divalent cations; and a stage of separation of the composition containing the D-psicose borate complex into a D-psicose containing fraction (i) and a borate containing fraction (ii) wherein divalent cations constitute one or more of calcium ions, barium ions and strontium ions.
EFFECT: invention allows synthesizing D-psicosis with a high degree of efficiency.
15 cl, 4 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL D-PSICOSE-3-EPIMERASE AND METHOD OF PRODUCING D-PSICOSE USING THEREOF | 2017 |
|
RU2727903C1 |
| NEW PSICOSE-6-PHOSPHATE PHOSPHATASE, COMPOSITION FOR PRODUCTION OF PSICOSE CONTAINING THE SPECIFIED ENZYME, METHOD FOR PRODUCTION OF PSICOSE USING THE SPECIFIED ENZYME | 2018 |
|
RU2757229C2 |
| ANTI-LILRB1 ANTIBODY AND ITS USE | 2020 |
|
RU2801535C1 |
| ANTI-LILRB1 ANTIBODY AND USES THEREOF | 2021 |
|
RU2813373C1 |
| LONG-ACTING FUSION PROTEIN GDF15 AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2020 |
|
RU2836280C1 |
| MODIFIED MITOCHONDRIA AND THEIR USE | 2019 |
|
RU2811467C2 |
| MUTATED SPOT PROTEIN AND METHOD OF PRODUCING L-AMINO ACIDS USING SAME | 2022 |
|
RU2837657C2 |
| ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF | 2020 |
|
RU2831838C2 |
| BISPECIFIC ANTI-EGFR/ANTI-4-1BB ANTIBODY AND USE THEREOF | 2020 |
|
RU2831836C2 |
| ANTIBODIES AGAINST PROGRAMMED CELL DEATH LIGAND 1 AND THEIR USE | 2020 |
|
RU2786235C1 |
